Literature DB >> 17148764

BRCA mutation frequency and penetrance: new data, old debate.

Kenneth Offit.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17148764     DOI： 10.1093/jnci/djj500

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  16 in total

1.  Understanding Genetic Breast Cancer Risk: Processing Loci of the BRCA Gist Intelligent Tutoring System.

Authors:  Christopher R Wolfe; Valerie F Reyna; Colin L Widmer; Elizabeth M Cedillos-Whynott; Priscila G Brust-Renck; Audrey M Weil; Xiangen Hu
Journal:  Learn Individ Differ       Date:  2016-07-01

2.  Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.

Authors:  Mia M Gaudet; Michael F Press; Robert W Haile; Charles F Lynch; Sally L Glaser; Joellen Schildkraut; Marilie D Gammon; W Douglas Thompson; Jonine L Bernstein
Journal:  Breast Cancer Res Treat       Date:  2011-06-11       Impact factor: 4.872

Review 3.  Is breast-conserving therapy adequate in BRCA 1/2 mutation carriers? The radiation oncologist's point of view.

Authors:  Alexis Vallard; Nicolas Magné; Jean-Baptiste Guy; Sophie Espenel; Chloé Rancoule; Peng Diao; Eric Deutsch; Sofia Rivera; Cyrus Chargari
Journal:  Br J Radiol       Date:  2019-02-27       Impact factor: 3.039

4.  Two decades after BRCA: setting paradigms in personalized cancer care and prevention.

Authors:  Fergus J Couch; Katherine L Nathanson; Kenneth Offit
Journal:  Science       Date:  2014-03-28       Impact factor: 47.728

5.  BRCA1 and BRCA2 families and the risk of skin cancer.

Authors:  Ophira M Ginsburg; Charmaine Kim-Sing; William D Foulkes; Parviz Ghadirian; Henry T Lynch; Ping Sun; Steven A Narod
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

6.  Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers.

Authors:  Sylviane Olschwang; Kai Yu; Christine Lasset; Stéphanie Baert-Desurmont; Marie-Pierre Buisine; Qing Wang; Pierre Hutter; Etienne Rouleau; Olivier Caron; Violaine Bourdon; Gilles Thomas
Journal:  J Cancer Epidemiol       Date:  2009-03-08

7.  Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.

Authors:  Mia M Gaudet; Tomas Kirchhoff; Todd Green; Joseph Vijai; Joshua M Korn; Candace Guiducci; Ayellet V Segrè; Kate McGee; Lesley McGuffog; Christiana Kartsonaki; Jonathan Morrison; Sue Healey; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Sylvie Mazoyer; Marion Gauthier-Villars; Hagay Sobol; Michel Longy; Marc Frenay; Frans B L Hogervorst; Matti A Rookus; J Margriet Collée; Nicoline Hoogerbrugge; Kees E P van Roozendaal; Marion Piedmonte; Wendy Rubinstein; Stacy Nerenstone; Linda Van Le; Stephanie V Blank; Trinidad Caldés; Miguel de la Hoya; Heli Nevanlinna; Kristiina Aittomäki; Conxi Lazaro; Ignacio Blanco; Adalgeir Arason; Oskar T Johannsson; Rosa B Barkardottir; Peter Devilee; Olofunmilayo I Olopade; Susan L Neuhausen; Xianshu Wang; Zachary S Fredericksen; Paolo Peterlongo; Siranoush Manoukian; Monica Barile; Alessandra Viel; Paolo Radice; Catherine M Phelan; Steven Narod; Gad Rennert; Flavio Lejbkowicz; Anath Flugelman; Irene L Andrulis; Gord Glendon; Hilmi Ozcelik; Amanda E Toland; Marco Montagna; Emma D'Andrea; Eitan Friedman; Yael Laitman; Ake Borg; Mary Beattie; Susan J Ramus; Susan M Domchek; Katherine L Nathanson; Tim Rebbeck; Amanda B Spurdle; Xiaoqing Chen; Helene Holland; Esther M John; John L Hopper; Saundra S Buys; Mary B Daly; Melissa C Southey; Mary Beth Terry; Nadine Tung; Thomas V Overeem Hansen; Finn C Nielsen; Mark H Greene; Mark I Greene; Phuong L Mai; Ana Osorio; Mercedes Durán; Raquel Andres; Javier Benítez; Jeffrey N Weitzel; Judy Garber; Ute Hamann; Susan Peock; Margaret Cook; Clare Oliver; Debra Frost; Radka Platte; D Gareth Evans; Fiona Lalloo; Ros Eeles; Louise Izatt; Lisa Walker; Jacqueline Eason; Julian Barwell; Andrew K Godwin; Rita K Schmutzler; Barbara Wappenschmidt; Stefanie Engert; Norbert Arnold; Dorothea Gadzicki; Michael Dean; Bert Gold; Robert J Klein; Fergus J Couch; Georgia Chenevix-Trench; Douglas F Easton; Mark J Daly; Antonis C Antoniou; David M Altshuler; Kenneth Offit
Journal:  PLoS Genet       Date:  2010-10-28       Impact factor: 5.917

8.  Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir.

Authors:  Joong Sup Shim; Rajini Rao; Kristin Beebe; Len Neckers; Inkyu Han; Rita Nahta; Jun O Liu
Journal:  J Natl Cancer Inst       Date:  2012-10-05       Impact factor: 13.506

9.  Efficacy of a web-based intelligent tutoring system for communicating genetic risk of breast cancer: a fuzzy-trace theory approach.

Authors:  Christopher R Wolfe; Valerie F Reyna; Colin L Widmer; Elizabeth M Cedillos; Christopher R Fisher; Priscila G Brust-Renck; Audrey M Weil
Journal:  Med Decis Making       Date:  2014-05-14       Impact factor: 2.583

10.  BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.

Authors:  Cristina R Ferrone; Douglas A Levine; Laura H Tang; Peter J Allen; William Jarnagin; Murray F Brennan; Kenneth Offit; Mark E Robson
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.